Loading...
Natalizumab in the treatment of multiple sclerosis
Natalizumab is a monoclonal antibody, representing a new class of medication for treating relapsing multiple sclerosis (MS). Conventional treatments include interferons, glatiramer acetate and chemotherapies such as mitoxantrone and cyclophosphamide. These therapies offer only modest clinical benefi...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2724189/ https://ncbi.nlm.nih.gov/pubmed/19707275 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|